| |
| |
|
| Insider
Information: |
Lynch Thomas J. Jr. |
| Relationship: |
EVP & Chief Scientific... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
22,223 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$996,702 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
22,223 |
|
|
| Total
Value |
$996,702 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP & Chief Scientific... |
2019-04-03 |
22,223 |
2017-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2019-04-03 |
4 |
D |
$46.88 |
$289,296 |
D/D |
(6,171) |
22,223 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2019-04-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(773) |
25,043 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2019-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,594 |
25,816 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2019-03-10 |
4 |
D |
$51.39 |
$122,462 |
D/D |
(2,383) |
17,573 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,387) |
19,956 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,864 |
21,343 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2018-04-03 |
4 |
D |
$62.77 |
$444,914 |
D/D |
(7,088) |
15,479 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2018-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
949 |
19,216 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2018-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,367 |
18,267 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2017-12-12 |
4 |
S |
$63.24 |
$335,172 |
D/D |
(5,300) |
9,251 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Scientific Officer |
• – – |
2017-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,551 |
14,551 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
